pirenzepine has been researched along with sumatriptan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Rozen, TD | 1 |
Benkelfat, C; Bienstock, CA; Greenberg, BD; Hollander, E; Koran, LM; Marazziti, D; Pallanti, S; Rasmussen, SA; Ravizza, L; Sasson, Y; Saxena, S; Zohar, J | 1 |
2 review(s) available for pirenzepine and sumatriptan
Article | Year |
---|---|
New treatments in cluster headache.
Topics: Anesthetics, Local; Benzodiazepines; Cluster Headache; Ergotamine; Humans; Lidocaine; Olanzapine; Oxygen; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Sumatriptan; Vasoconstrictor Agents | 2002 |
Refractory obsessive-compulsive disorder: state-of-the-art treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Fluvoxamine; Humans; Morphine; Multicenter Studies as Topic; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Retrospective Studies; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sumatriptan; Treatment Outcome | 2002 |
3 other study(ies) available for pirenzepine and sumatriptan
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |